— Know what they know.
Not Investment Advice

RGNX NASDAQ

REGENXBIO Inc.
1W: +8.2% 1M: -27.7% 3M: -17.1% YTD: -50.3% 1Y: -32.5% 3Y: -65.8% 5Y: -81.3%
$6.35
-0.40 (-5.93%)
 
Weekly Expected Move ±21.1%
$3 $5 $6 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 25 · $328.3M mcap · 43M float · 2.57% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$88M
Revenue
-44.0% YoY
$-290M
Net Income
-83.9% YoY
$-236M
Free Cash Flow
-171.9% YoY
-73.2%
Gross Margin
-1304.0%
Op. Margin
-1408.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-160.1%
ROA-63.1%
ROIC-152.3%

Valuation

P/E-1.1
P/B15.8
EV/EBITDA-2.0

Leverage

Debt/Equity2.54
Current Ratio2.38
Interest Cov.-8.9x

Quality Scores

Piotroski F1/9
Altman Z-3.90
Beneish M7.38

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms